Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare Fund
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
Motilal Oswal BSE Healthcare ETF is an ETF fund and WhiteOak Capital Pharma and Healthcare Fund is a Sectoral fund. In the year to 30-10-2026, Motilal Oswal BSE Healthcare ETF returned 12.2% and WhiteOak Capital Pharma and Healthcare Fund (Direct) returned 19.5%. Motilal Oswal BSE Healthcare ETF charges 0.36% a year and WhiteOak Capital Pharma and Healthcare Fund 1.07%. Their portfolios overlap 54.5%: they hold 41 of the same securities.
Motilal Oswal BSE Healthcare ETF
ETF
- 1 year return
- 12.2%
- Expense ratio
- 0.36%
- NAV
- ₹50.91
WhiteOak Capital Pharma and Healthcare Fund
Sectoral
- 1 year return
- 19.5%
- Expense ratio
- 1.07%
- NAV
- ₹17.44
Which is better, Motilal Oswal BSE Healthcare ETF or WhiteOak Capital Pharma and Healthcare? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- WhiteOak Capital Pharma and Healthcare returned more over 1 year: 19.5% against 12.2%.
- Motilal Oswal BSE Healthcare ETF costs less: 0.36% a year against 1.07%.
- WhiteOak Capital Pharma and Healthcare fell less in its worst fall since 07-02-2024: −15.4% against −16.1%.
- WhiteOak Capital Pharma and Healthcare is the larger fund: ₹927 Cr against ₹44 Cr.
- Their portfolios overlap 54.5%: 41 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund |
|---|---|---|
| Fund house | Motilal Oswal Mutual Fund | WhiteOak Capital Mutual Fund |
| Category | ETF | Sectoral |
| AUM | ₹44 Cr (30-09-2026) | ₹927 Cr (30-09-2026) |
| NAV | ₹50.91 | ₹17.44 (Direct) |
| Expense ratio (Direct) | Not available | 1.07% |
| Expense ratio (Regular) | Not available | 2.75% |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | BSE Healthcare TRI |
| Launch date | 29-07-2022 | 06-02-2024 |
| Minimum investment | ₹500 | ₹500 |
| Lock in | None | None |
| Fund managers | Swapnil Mayekar, Rakesh Shetty | Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Trupti Agrawal |
| Exit load | Nil | Nil |
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | +0.22% | −1.05% | +12.72% | +12.16% | +22.69% | -- | -- |
| WhiteOak Capital Pharma and Healthcare Fund (Direct) | +0.92% | +1.33% | +17.99% | +19.53% | -- | -- | -- |
| Sectoral average | −1.70% | −4.49% | +2.30% | −0.58% | -- | -- | -- |
Category average: the average of the 20 Sectoral funds, same plan type.
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Year-wise Returns
| Year | Motilal Oswal BSE Healthcare ETFMotilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and HealthcareWhiteOak Capital Pharma and Healthcare | BSE Healthcare TRI |
|---|---|---|---|
| 2026to date | +14.90% | +22.83% | +15.08% |
| 2025 | −2.93% | +1.84% | −2.72% |
| 2024 | +43.80% | -- | +44.30% |
| 2023 | +37.59% | -- | +37.97% |
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of both
Rolling returns
Every 1-year holding period, 425 of them, one for each trading day from 07-02-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Motilal Oswal BSE Healthcare ETF
WhiteOak Capital Pharma and Healthcare Fund (Direct)
BSE Healthcare TRI
to
Mar 2025Jul 2024
to
Jul 2025Oct 2024
to
Oct 2025Feb 2025
to
Feb 2026May 2025
to
May 2026Sept 2025
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 10.4 | 19.3 | 17.2 | 24.9 | 20.9 | 7.3 | 0.0 | 9.9% | 10.8% | −3.9% | 24.4% | 1% |
| WhiteOak Capital Pharma and Healthcare | 0.0 | 6.6 | 14.9 | 16.3 | 18.6 | 19.3 | 24.3 | 18.0% | 18.4% | 0.6% | 35.5% | 100% |
| BSE Healthcare TRI | 9.6 | 19.1 | 17.2 | 24.9 | 20.5 | 8.7 | 0.0 | 10.2% | 10.9% | −3.7% | 24.8% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 07-02-2024. Past returns do not promise future returns.
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 01-02-2024 to 30-10-2026: 33 instalments, ₹3,30,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETFMotilal Oswal BSE Healthcare ETF | ₹3,30,000 | ₹3,94,576 | ₹64,576 | 13.1% |
| WhiteOak Capital Pharma and HealthcareWhiteOak Capital Pharma and Healthcare Fund (Direct) | ₹3,30,000 | ₹4,37,625 | ₹1,07,625 | 21.2% |
Motilal Oswal BSE Healthcare ETFMotilal Oswal BSE Healthcare ETF
WhiteOak Capital Pharma and HealthcareWhiteOak Capital Pharma and Healthcare Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +12.16% | +19.53% |
| Standard deviation | 13.58% | 13.75% |
| Sharpe ratio | 0.51 | 1.04 |
| Sortino ratio | 0.75 | 1.57 |
| Maximum drawdown | −10.0% (23-10-2026) | −9.8% (23-10-2026) |
| Beta | 1.00 | 0.97 |
| Alpha | −0.20% | +7.36% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +20.31% | +22.30% |
| Standard deviation | 13.22% | 14.35% |
| Sharpe ratio | 1.07 | 1.14 |
| Sortino ratio | 1.54 | 1.62 |
| Maximum drawdown | −16.1% (28-02-2025) | −15.4% (28-02-2025) |
| Beta | 1.00 | 0.97 |
| Alpha | −0.29% | +7.59% |
From daily NAVs, 04-08-2022 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Motilal Oswal BSE Healthcare ETF
WhiteOak Capital Pharma and Healthcare Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | −16.1% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
| WhiteOak Capital Pharma and Healthcare Fund (Direct) | −15.4% | 02-01-2025 | 28-02-2025 | 14-07-2025 | 4 months | −3.0% |
| BSE Healthcare TRI | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
From daily values since 07-02-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Motilal Oswal BSE Healthcare ETF
WhiteOak Capital Pharma and Healthcare Fund (Direct)
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 99% | 100% | 0.06% |
| WhiteOak Capital Pharma and Healthcare Fund (Direct) | 116% | 90% | 3.43% |
From month-end values since 07-02-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Portfolio Overlap
From each fund's latest monthly portfolio: Motilal Oswal BSE Healthcare ETF, September 2026; WhiteOak Capital Pharma and Healthcare Fund, September 2026
Holdings in common
- Overlap
- 54.5%
- Held by both
- 41
- Only in Motilal Oswal BSE Healthcare ETF
- 96
- Only in WhiteOak Capital Pharma and Healthcare
- 18
| Security | % of Motilal Oswal BSE Healthcare ETF | % of WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Divi's Laboratories Limited | 7.42% | 8.36% |
| Sun Pharmaceutical Industries Limited | 12.33% | 7.11% |
| Laurus Labs Limited | 4.84% | 3.91% |
| Apollo Hospitals Enterprise Limited | 5.21% | 3.75% |
| Cipla Limited | 4.79% | 3.68% |
| Torrent Pharmaceuticals Limited | 3.55% | 6.26% |
| Aurobindo Pharma Limited | 2.89% | 2.09% |
| Max Healthcare Institute Limited | 4.32% | 1.84% |
| Zydus Lifesciences Limited | 1.82% | 2.81% |
| IPCA Laboratories Limited | 1.69% | 2.88% |
| Fortis Healthcare Limited | 2.51% | 1.36% |
| Sai Life Sciences Limited | 1.30% | 3.28% |
| Krishna Institute Of Medical Sciences Limited | 1.24% | 1.85% |
| Mankind Pharma Limited | 1.75% | 1.20% |
| Neuland Laboratories Limited | 1.16% | 2.60% |
| Acutaas Chemicals Limited | 1.06% | 1.45% |
| Ajanta Pharma Limited | 1.02% | 2.01% |
| Dr. Lal Path Labs Limited | 0.96% | 2.35% |
| Gland Pharma Limited | 1.44% | 0.93% |
| Piramal Pharma Limited | 0.81% | 1.06% |
| Narayana Hrudayalaya Limited | 0.78% | 1.61% |
| Global Health Limited | 0.76% | 1.82% |
| Onesource Specialty Pharma Limited | 0.75% | 1.55% |
| Anthem Biosciences Limited | 0.58% | 1.57% |
| Vijaya Diagnostic Centre Limited | 0.45% | 1.56% |
| Biocon Limited | 1.63% | 0.42% |
| Rainbow Childrens Medicare Limited | 0.42% | 1.15% |
| Aarti Pharmalabs Limited | 0.31% | 1.20% |
| Jupiter Life Line Hospitals Limited | 0.30% | 0.73% |
| Procter & Gamble Health Limited | 0.28% | 1.18% |
| Corona Remedies Limited | 0.25% | 2.34% |
| Senores Pharmaceuticals Limited | 0.22% | 0.80% |
| Thyrocare Technologies Limited | 0.21% | 2.27% |
| Kovai Medical Center and Hospital Limited | 0.17% | 0.95% |
| Supriya Lifescience Limited | 0.15% | 0.69% |
| Nephrocare Health Services Ltd | 0.15% | 0.57% |
| Innova Captab Limited | 0.12% | 0.63% |
| Orchid Pharma Limited | 0.10% | 0.41% |
| Novartis India Limited | 0.09% | 0.24% |
| Vimta Labs Limited | 0.06% | 0.67% |
| Laxmi Dental Limited | 0.02% | 0.23% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 54.5% means 54.5% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Motilal Oswal BSE Healthcare ETF
| Security | % of fund |
|---|---|
| Dr Reddys Laboratories Limited | 4.73% |
| Lupin Limited | 3.11% |
| Glenmark Pharmaceuticals Limited | 2.17% |
| Alkem Laboratories Limited | 1.89% |
| Aster DM Quality Care Limited | 1.18% |
Largest holdings only in WhiteOak Capital Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Shaily Engineering Plastics Limited | 1.84% |
| Navin Fluorine International Limited | 1.41% |
| Molbio Diagnostics Limited | 1.15% |
| Aether Industries Limited | 1.05% |
| 91 Days Tbill (MD 03/12/2026) | 0.60% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Equity | 99.9% | 90.7% |
| Debt | 0.0% | 3.1% |
| Cash and others | 0.1% | 6.1% |
Market cap of stocks
| Market cap | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Large Cap | 33.3% | 29.2% |
| Mid Cap | 38.5% | 21.7% |
| Small Cap | 27.8% | 37.5% |
| Not on AMFI's list | 0.3% | 2.4% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare |
|---|---|---|
| Pharmaceuticals & Biotechnology | 78.0% | 61.2% |
| Healthcare Services | 21.4% | 23.0% |
| Chemicals & Petrochemicals | 0.0% | 3.3% |
| Consumer Durables | 0.0% | 1.8% |
| Healthcare Equipment & Supplies | 0.5% | 1.4% |
The six largest sectors of each fund's stocks, % of the fund.
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Motilal Oswal BSE Healthcare ETF | WhiteOak Capital Pharma and Healthcare Fund |
|---|---|---|
| Total expense ratio (Direct) | Not available | 1.07% |
| Base expense ratio (Direct) | 0.00% | 0.54% |
| Total expense ratio (Regular) | Not available | 2.75% |
| Base expense ratio (Regular) | 0.21% | 1.96% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare WhiteOak Capital Pharma and Healthcare with
- WhiteOak Capital Pharma and Healthcare vs DSP Healthcare
- WhiteOak Capital Pharma and Healthcare vs Nippon India Pharma
- WhiteOak Capital Pharma and Healthcare vs Bandhan Transportation and Logistics
- WhiteOak Capital Pharma and Healthcare vs Nippon India Power & Infra
- WhiteOak Capital Pharma and Healthcare vs Invesco India Financial Services
Motilal Oswal BSE Healthcare ETF vs WhiteOak Capital Pharma and Healthcare Fund: Frequently Asked Questions
What is the difference between Motilal Oswal BSE Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund?
Motilal Oswal BSE Healthcare ETF is an ETF fund, WhiteOak Capital Pharma and Healthcare Fund is a Sectoral fund, run by Motilal Oswal Mutual Fund and WhiteOak Capital Mutual Fund. Their portfolios overlap 54.5%. Motilal Oswal BSE Healthcare ETF charges 0.36% a year and WhiteOak Capital Pharma and Healthcare Fund 1.07%.
Which has given higher returns, Motilal Oswal BSE Healthcare ETF or WhiteOak Capital Pharma and Healthcare Fund?
Over 1 year: Motilal Oswal BSE Healthcare ETF +12.16%, WhiteOak Capital Pharma and Healthcare Fund +19.53%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Motilal Oswal BSE Healthcare ETF or WhiteOak Capital Pharma and Healthcare Fund?
Motilal Oswal BSE Healthcare ETF charges less: 0.36% a year against 1.07%. These are the total expense ratios reported to AMFI.
How much do Motilal Oswal BSE Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund overlap?
54.5%. They hold 41 of the same securities, the largest shared ones being DIVISLAB, SUNPHARMA, LAURUSLABS. From each fund's latest monthly portfolio.
Which is riskier, Motilal Oswal BSE Healthcare ETF or WhiteOak Capital Pharma and Healthcare Fund?
On SEBI's riskometer, Motilal Oswal BSE Healthcare ETF is rated Very High and WhiteOak Capital Pharma and Healthcare Fund Very High. Over 1 years, the standard deviation of daily returns was 13.58% and 13.75% a year.
Can I invest in both Motilal Oswal BSE Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund?
Yes. 54.5% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages Motilal Oswal BSE Healthcare ETF and WhiteOak Capital Pharma and Healthcare Fund?
Motilal Oswal BSE Healthcare ETF: Swapnil Mayekar, Rakesh Shetty. WhiteOak Capital Pharma and Healthcare Fund: Ramesh Mantri, Piyush Baranwal, Dheeresh Pathak, Ashish Agrawal, Trupti Agrawal.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.